Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as a

Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 88, 530350, 530352, 530395, 530825, 435 68, A61K 39104, C07K 1504

Patent

active

047029102

ABSTRACT:
PSC-A is a new serological common antigen to Pseudomonas aeruginosa having very low toxicity, and highly effective for protecting infection by any of the serotypes of Pseudomonas aeruginosa. PSC-A can be used as the active component in a pharmaceutical agent for protecting Pseudonomas aeruginosa infection.

REFERENCES:
patent: 4428931 (1984-01-01), Tolman et al.
patent: 4575459 (1986-03-01), Homma et al.
patent: 4578458 (1986-03-01), Pier

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as a will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1271377

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.